The Ottawa Hospital is conducting cutting-edge research to improve our understanding of bladder cancer and develop better treatments. This page includes selected news stories about our bladder cancer research, links to researchers working in this area and related resources. Learn more below.
Researchers
Morgan, Scott
MD, MSc, FRCPC
|
Clinician Investigator
(CR)
|
Bladder cancer, Breast cancer, Cancer, Prostate cancer
|
Biomarkers, Clinical research, Clinical trials, Cohort studies, Imaging, Systematic reviews
|
Clinical Trials
The following list of clinical trials is pulled from ClinicalTrials.gov using the search terms "Bladder cancer” and “Ottawa Hospital.” More advanced search options are available. If you find a clinical trial that interests you, you can bring the information to the next appointment with your care team and ask if you are eligible for the study. If so, they may be able to refer you to the study team. Visit ohri.ca/patients to learn more about participating in research and clinical trials.
Note that ClinicalTrials.gov is hosted by the U.S. National Library of Medicine and is only available in English. Please note that we cannot guarantee a response from the person listed in the ‘Contact’ column.
NCT | Title | Condition | Status | Contact |
NCT06129084 | A Study to Compare the Results of FGFR Testing by Either CtDNA Blood Testing or Standard Tumor Tissue Testing (NCT06129084) | Metastatic Bladder Cancer, Metastatic Urothelial Carcinoma | RECRUITING | |
NCT04260802 | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers (NCT04260802) | Cancer, Neoplasms, Metastatic Cancer, Triple Negative Breast Cancer, Gastric Cancer, Cervical Cancer, Ovarian Cancer, Hepatocellular Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma, Urothelial Neoplasm, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Locally Advanced Solid Tumor, Locally Advanced Malignant Neoplasm, Squamous Cell Carcinoma, Sarcoma, Merkel Cell Carcinoma, Bladder Cancer | RECRUITING | |
NCT04574960 | Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL) (NCT04574960) | Bladder Cancer, Bladder Urothelial Carcinoma | RECRUITING | |
NCT04543110 | Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC (NCT04543110) | Bladder Cancer | RECRUITING | caproulx@ohri.ca |